Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Debt Ratio (2022 - 2025)

Historic Debt Ratio for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to 0.16.

  • Taysha Gene Therapies' Debt Ratio fell 3262.78% to 0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16, marking a year-over-year decrease of 3262.78%. This contributed to the annual value of 0.27 for FY2024, which is 1684.29% up from last year.
  • Per Taysha Gene Therapies' latest filing, its Debt Ratio stood at 0.16 for Q3 2025, which was down 3262.78% from 0.12 recorded in Q2 2025.
  • Taysha Gene Therapies' 5-year Debt Ratio high stood at 0.91 for Q3 2023, and its period low was 0.12 during Q2 2025.
  • Moreover, its 4-year median value for Debt Ratio was 0.26 (2024), whereas its average is 0.31.
  • As far as peak fluctuations go, Taysha Gene Therapies' Debt Ratio surged by 16994.59% in 2023, and later crashed by 7393.42% in 2024.
  • Over the past 4 years, Taysha Gene Therapies' Debt Ratio (Quarter) stood at 0.3 in 2022, then decreased by 22.0% to 0.23 in 2023, then increased by 16.84% to 0.27 in 2024, then crashed by 41.37% to 0.16 in 2025.
  • Its Debt Ratio was 0.16 in Q3 2025, compared to 0.12 in Q2 2025 and 0.31 in Q1 2025.